Age-related Memory Impairment

• CLINICAL_TRIALS trial_result · 2019-01-15
  Clinical Trial Update: A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints [Phase 4]

  Phase 4 trial update of EGb 761 (Tanakan) in memory complaints and dementia of Alzheimer type.

• CLINICAL_TRIALS trial_result · 2010-03-03
  Clinical Trial Update: Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment [Phase 2]

  Phase 2 study of LX6171 in elderly volunteers with age-related memory impairment completed; results were posted in 2010.

• CLINICAL_TRIALS trial_result · 2008-07-18
  Clinical Trial Update: A Safety and Efficacy Study of Ispronicline (TC-1734-112) in Subjects With Age Associated Memory Impairment (AAMI) [Phase 2]

  A Phase 2 safety and efficacy study of Ispronicline (TC-1734-112) for age-related memory disorders has completed.